Compare ICLR & RNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICLR | RNR |
|---|---|---|
| Founded | 1990 | 1993 |
| Country | Ireland | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 13.6B |
| IPO Year | 2001 | 1996 |
| Metric | ICLR | RNR |
|---|---|---|
| Price | $164.55 | $328.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 14 |
| Target Price | $178.62 | ★ $322.31 |
| AVG Volume (30 Days) | ★ 712.4K | 239.1K |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.53% |
| EPS Growth | N/A | ★ 59.13 |
| EPS | N/A | ★ 6.57 |
| Revenue | N/A | ★ $12,848,074,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.19 |
| P/E Ratio | ★ $12.91 | $50.04 |
| Revenue Growth | N/A | ★ 9.86 |
| 52 Week Low | $66.57 | $231.17 |
| 52 Week High | $203.91 | $340.24 |
| Indicator | ICLR | RNR |
|---|---|---|
| Relative Strength Index (RSI) | 45.51 | 53.19 |
| Support Level | $162.06 | $316.11 |
| Resistance Level | $183.11 | $335.24 |
| Average True Range (ATR) | 6.17 | 5.89 |
| MACD | 0.24 | -0.31 |
| Stochastic Oscillator | 29.62 | 46.91 |
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.